CRISPR Co-inventor Jennifer Doudna on Future of Biotech
Sixth Street Chief Science Adviser and Nobel laureate Jennifer Doudna, co-founder of the CRISPR genome editing technology, and Sixth Street Vice Chairman and Partner R. Martin Chavez join Emily Chang to discuss the future of CRISPR and its potential for commercialization. To learn more, read the announcement press release here.
